Table 2. Expected proteins of labeled IN spots whose intensity increased more than two-fold compared with the control in Figure 1B according to MS analysis.
| Spot | Protein name | Spot | Protein name |
|---|---|---|---|
| IN01 | Actin | IN06 | Amphiphysin II |
| IN02 | Actin | SETD 8 protein | |
| IN03 | Cytokeratin 2,9 | IN07 | Ankyrin repeat domain |
| Translation elongation factor | p 107 | ||
| Plasminogen | IN08 | PNAS-102 | |
| Apolipoprotein B mRNA editing enzyme | Heterogeneous nuclear ribonucleoprotein H | ||
| IN04 | MEGF5 | Glutathione peroxidase | |
| Cerebrin 30 | IN09 | Unnamed protein | |
| Cytokeratin 9 | IN10 | Actin, talin | |
| IN05 | Cytokeratin 9 | POTE ankyrin domain family |